Wave Life Sciences Ltd.’s recent filing unveils that its Chief Financial Officer Moran Kyle unloaded Company’s shares for reported $96421.0 on Apr 03 ’24. In the deal valued at $6.17 per share,15,630 shares were sold. As a result of this transaction, Moran Kyle now holds 33,921 shares worth roughly $0.2 million.
Then, RA CAPITAL MANAGEMENT, L.P. bought 1,000,000 shares, generating $5,000,000 in total proceeds. Upon buying the shares at $5.00, the Director now owns 19,202,009 shares.
Before that, GSK plc bought 3,300,000 shares. Wave Life Sciences Ltd. shares valued at $16,500,000 were divested by the 10% Owner at a price of $5.00 per share. As a result of the transaction, GSK plc now holds 13,983,761 shares, worth roughly $81.11 million.
Leerink Partners upgraded its Wave Life Sciences Ltd. [WVE] rating to an Outperform from a a Market perform in a research note published on December 19, 2023; the price target was increased to $12 from $5. A number of analysts have revised their coverage, including Raymond James’s analysts, who began to cover the stock in early July with a ‘”an Outperform”‘ rating. Jefferies also remained covering WVE and has decreased its forecast on May 24, 2023 with a “Hold” recommendation from previously “Buy” rating.
Price Performance Review of WVE
On Friday, Wave Life Sciences Ltd. [NASDAQ:WVE] saw its stock fall -3.33% to $5.80. Over the last five days, the stock has lost -1.86%. Wave Life Sciences Ltd. shares have risen nearly 14.85% since the year began. Nevertheless, the stocks have risen 24.73% over the past one year. While a 52-week high of $7.67 was reached on 03/07/24, a 52-week low of $3.15 was recorded on 02/14/24. SMA at 50 days reached $5.28, while 200 days put it at $5.00. A total of 0.65 million shares were traded, compared to the trading of 0.55 million shares in the previous session.
Levels Of Support And Resistance For WVE Stock
The 24-hour chart illustrates a support level at 5.60, which if violated will result in even more drops to 5.39. On the upside, there is a resistance level at 6.07. A further resistance level may holdings at 6.34. The Relative Strength Index (RSI) on the 14-day chart is 49.48, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.01, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 60.47%. Stochastics %K at 56.59% indicates the stock is a holding.
The most recent change occurred on October 23, 2020 when RBC Capital Mkts began covering the stock and recommended ‘”a Sector perform”‘ rating along with a $13 price target.
